Juanita Lopez - Dissemin

Papers authored by Juanita Lopez

This paper was not found in any repository, but could be made available legally by the author.

2018 Terri Patricia McVeigh, Raghav Sundar, Nikolaos Diamantis, Stan B. Kaye, Udai Banerji

, Juanita S. Lopez

, Johann de Bono

, Winette T. A. van der Graaf, Angela J. George

The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials

Upload

Niamh Coleman

, Vasiliki Michalarea, Scheryll Alken, Karim Rihawi, Raquel Perez Lopez, Nina Tunariu, Ann Petruckevitch, L. R. Molife, Udai Banerji, Johann S. De Bono

, Liam Welsh, Frank Saran, Juanita Lopez

Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience

Upload

Dearbhaile C. Collins, Maxime Chenard-Poirier, Juanita S. Lopez

The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations

Upload

This paper is made freely available by the publisher.

Malaka Ameratunga, Niamh Coleman, Liam Welsh, Frank Saran, Juanita Lopez

CNS cancer immunity cycle and strategies to target this for glioblastoma

Download from doi.org

R. Sundar, A. Custodio, A. Petruckevich, M. Chénard-Poirier, M. Ameratunga, D. Collins, J. Lim, S. B. Kaye, N. Tunariu, U. Banerji, J. de Bono

, J. Lopez

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit

Download from doi.org

Anna Minchom

, Caterina Aversa, Juanita Lopez

Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies

Download from doi.org

Malaka Ameratunga

, Maxime Chénard-Poirier, Irene Moreno Candilejo, Manuel Pedregal, Andrew Lui, David Dolling, Caterina Aversa, Alvaro Ingles Garces

, Joo Ern Ang, Udai Banerji

, Stan Kaye

, Hui Gan, Bernard Doger, Victor Moreno

, Johann de Bono

and 1 other authors

Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors

Upload

Niamh Coleman

, Malaka Ameratunga, Juanita Lopez

Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach

Download from doi.org

2017 Jessica S. Brown, Raghav Sundar, Juanita Lopez

Combining DNA damaging therapeutics with immunotherapy: more haste, less speed

Download from www.nature.com

Raquel Perez-Lopez, Desam Roda, Begona Jimenez, Jessica Brown, Joaquin Mateo, Suzanne Carreira, Juanita Lopez

, Udai Banerji, L. Rhoda Molife, Dow-Mu Koh, Stan B. Kaye, Johann S. de Bono

, Nina Tunariu, Timothy A. Yap

High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy

Download from doi.org

Patrick A. Ott, Yung-Jue Bang, Dominique Berton-Rigaud, Elena Elez

, Michael J. Pishvaian, Hope S. Rugo, Igor Puzanov, Janice M. Mehnert, Kyaw L. Aung, Juanita Lopez

, Marion Carrigan, Sanatan Saraf, Mei Chen, Jean-Charles Soria

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

Download from doi.org

Evan W. Alley, Juanita Lopez

, Armando Santoro

, Anne Morosky, Sanatan Saraf, Bilal Piperdi, Emilie van Brummelen

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

Upload

Angela George, Rebecca Kristeleit, Saeed Rafii, Caroline O. Michie, Rebecca Bowen, Vasiliki Michalarea, Tom van Hagen, Mabel Wong, Grigorios Rallis, L. Rhoda Molife, Juanita Lopez

, Udai Banerji, Susana N. Banerjee

, Martin E. Gore, Johann S. de Bono

and 2 other authors

Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials

Upload

Joline Sj Lim, Raghav Sundar, Maxime Chénard-Poirier, Juanita Lopez

, Timothy A. Yap

Emerging biomarkers for PD-1 pathway cancer therapy

Upload

2016 Saoirse O. Dolly, Eleftheria Kalaitzaki, Martina Puglisi, Sarah Stimpson, Janet Hanwell, Sonia Serrano Fandos, Sarah Stapleton, Thushara Ansari, Clare Peckitt, Stan Kaye, Juanita Lopez

, Timothy A. Yap, Winette van der Graaf, Johann de Bono

, Udai Banerji

A study of motivations and expectations of patients seen in phase 1 oncology clinics

Download from onlinelibrary.wiley.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Juanita S. Lopez

, Udai Banerji

Combine and conquer: challenges for targeted therapy combinations in early phase trials

Upload

2015 Timothy A. Yap, Juanita Lopez

, Sam Harris, Desam Roda

Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials

Download from doi.org

This paper is available in a repository.

2013 J. Lopez

, S. Banerjee

, S. B. Kaye

New developments in the treatment of ovarian cancer—future perspectives

Download from www.ncbi.nlm.nih.gov

2011 Tencho Tenev, Katiuscia Bianchi, Maurice Darding, Meike Broemer, Claudia Langlais, Fredrik Wallberg, Anna Zachariou, Juanita Lopez

, Marion MacFarlane, Kelvin Cain, Pascal Meier

The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs

Download from www.researchgate.net

Juanita Lopez

, Sidonie Wicky John, Tencho Tenev, Gilles J. P. Rautureau, Mark G. Hinds, Floriana Francalanci, Rebecca Wilson, Meike Broemer, Massimo M. Santoro

, Catherine L. Day, Pascal Meier

CARD-Mediated Autoinhibition of cIAP1's E3 Ligase Activity Suppresses Cell Proliferation and Migration

Download from www.researchgate.net

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Juanita Lopez